Clinical Trial Update: Efficacy and Safety Study of Alogliptin and Insulin in the Treatment of Type 2 Diabetes. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the efficacy and safety of combining alogliptin with insulin in Type 2 diabetes; the study completed and results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Alogliptin (alogliptin)
• Insulin (insulin)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2011-08-12